Still, better than most biotechs navigating this multi-year black swan, even setting a new monthly revenue mark. I’ll be surprised if growth doesn’t accelerate out of the back end of the nightmare environment of the last 16 m9nths.
Ann: FY21 BTM Revenue Results, page-131
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.35 |
Change
-0.195(7.68%) |
Mkt cap ! $1.628B | |||
| Open | High | Low | Value | Volume |
| $2.47 | $2.48 | $2.34 | $2.753M | 1.146M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 13770 | $2.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.35 | 14073 | 12 |
View Market Depth
| Last trade - 11.01am 05/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |